GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Syngene International Ltd (BOM:539268) » Definitions » Research & Development

Syngene International (BOM:539268) Research & Development : ₹0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Syngene International Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Syngene International's Research & Development for the three months ended in Mar. 2025 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0 Mil.


Syngene International Research & Development Historical Data

The historical data trend for Syngene International's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syngene International Research & Development Chart

Syngene International Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Syngene International Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Syngene International Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syngene International  (BOM:539268) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Syngene International Research & Development Related Terms

Thank you for viewing the detailed overview of Syngene International's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Syngene International Business Description

Traded in Other Exchanges
Address
Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The Company is engaged in a single operating segment of providing contract research and manufacturing services. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.

Syngene International Headlines

No Headlines